Navigation Links
Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
Date:9/13/2007

rtainties. Additional information concerning these forward-looking statements and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2006 and in the Company's other periodic reports and filings with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in the presentation. All forward-looking statements are based on information currently available to the Company on the date thereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this presentation, except as required by law.


'/>"/>
SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... DNDN ) today reported results for the year and quarter ended ... was $48.1 million compared to $0.1 million for the year ended ... $25.0 million compared to $21,000 for the quarter ended December 31, ... 31, 2010 was $439.5 million, or $3.18 per share, compared to ...
... Oncology Solutions (D3), formerly D3 Radiation Oncology Solutions, ... to the company,s suite of solutions. With this ... to both medical and radiation oncology practices across ... algorithms that standardize best practice cancer treatment, optimize ...
... Inc. announced today that the WARFARIN Study ( W arfarin ... A dults R eceiving Genetic Testing at Therapy ... in Bellevue and other major hospital systems nationwide to assess ... dose for individual patients to reduce their risk of serious ...
Cached Biology Technology:Dendreon Reports Fourth Quarter and 2010 Year End Financial Results 2Dendreon Reports Fourth Quarter and 2010 Year End Financial Results 3Dendreon Reports Fourth Quarter and 2010 Year End Financial Results 4D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology 2WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 2WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 3WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 4
(Date:4/15/2014)... American Association of Anatomists (AAA) is honored to announce ... presented during the Closing Awards Ceremony being held at ... at 7:30 p.m. during AAA,s 2014 Annual Meeting at ... winners are: , Henry Gray/Elsevier Distinguished Educator ... of Medicine at Mount Sinai, Past-President of the American ...
(Date:4/15/2014)... many viral diseases in the world for which no ... which is spread by mosquitoes in the tropics, as ... familiar in Finland and is easily spread by the ... and the elderly. , Researchers at Aalto University and ... preliminary tests to prevent the spread of one type ...
(Date:4/15/2014)... research into parasites of cuttlefish, squid and octopus ... cycles, and shown how they may help in ... Sarah Catalano has described 10 new parasite species− ... of cephalopods (cuttlefish, squid and octopus). They ... described from Australian waters. , "Although dicyemid ...
Breaking Biology News(10 mins):American Association of Anatomists 2014 award winners 2Nanocrystalline cellulose modified into an efficient viral inhibitor 2Bizarre parasite may provide cuttlefish clues 2
... CHICAGO, Ill. (March 29, 2011)The growth and spread of ... treatment that combines two innovative strategies: blocking the enzyme ... drug directly into the tumor, with minimum exposure to ... Radiology,s 36th Annual Scientific Meeting in Chicago, Ill. ...
... developed by retired U.S. Navy sonar experts, using submarine ... and monitoring of stroke, says a team of interventional ... Scientific Meeting in Chicago, Ill. Each type of stroke ... a simple headset and portable laptop-based console. The device,s ...
... with information on the size of the carbon footprint ... make better, environmentally friendly choices. A Michigan State ... of the journal Nature Climate Change , said ... with nutritional information, could offer at least a short-term ...
Cached Biology News:Interventional radiologists provide hope in delaying growth, spread of breast cancer 2Interventional radiologists provide hope in delaying growth, spread of breast cancer 3New device uses submarine technology to diagnose stroke quickly 2New device uses submarine technology to diagnose stroke quickly 3Nature paper calls for carbon labeling 2
... Agencourt offers quick turnaround sequencing of ... copy and high copy plasmids. Agencourt's world-class, ... million Phred20 bases per day. The ... Sequencing service are 24 48 hour ...
Great for biotinylating DNA/RNA probes...
...
...
Biology Products: